June 8, 2026
Incretin Economics: Strategic Lessons from New Obesity Therapies
The accelerating development of incretin-based therapies demands fresh thinking on incretin economics. Recent…
June 1, 2026
US Drug Pricing Trends and Global Comparisons
US drug pricing continues to shape debates on affordability and market access. Recent…
May 25, 2026
Barriers to Gene Therapy Access in Europe
Gene therapy access continues to challenge healthcare systems across Europe despite clear patient…
May 18, 2026
Why Indirect Healthcare Costs Deserve Greater Attention
Many reimbursement decisions still overlook indirect healthcare costs. These expenses arise from lost…
May 11, 2026
Building Effective Biosimilar Portfolios
The US biosimilar market has matured significantly, moving beyond single-product competition toward comprehensive…
May 4, 2026
US Oncology Innovation Sets New Standards for Cancer Care
The United States continues to lead the world in cancer research through consistent…